Blog

  • Meta investigated over AI having ‘sensual’ chats with children

    Meta investigated over AI having ‘sensual’ chats with children

    Charlotte Edwards

    Technology reporter, BBC News

    Getty Images A black smartphone displaying Meta AI is shown next to a background of a post for Meta AIGetty Images

    A US senator is opening an investigation into Meta after a leaked document reportedly showed the tech giant’s artificial intelligence (AI) was permitted to have “sensual” and “romantic” chats with children.

    The internal document, obtained by Reuters, was reportedly titled “GenAI: Content Risk Standards”.

    Republican Senator Josh Hawley called the document “reprehensible and outrageous” and has asked to see the document alongside a list of products it relates to.

    A Meta spokesperson told the BBC: “The examples and notes in question were and are erroneous and inconsistent with our policies, and have been removed.”

    They said the tech giant has “clear policies” on what responses its AI chatbots can offer, and said its policies “prohibit content that sexualizes children and sexualized role play between adults and minors”.

    “Separate from the policies, there are hundreds of examples, notes, and annotations that reflect teams grappling with different hypothetical scenarios,” they said.

    Senator Josh Hawley, a Republican from Missouri, announced he was probing Meta in a post on X on 15 August.

    “Is there anything – ANYTHING – Big Tech won’t do for a quick buck,” he said.

    “Now we learn Meta’s chatbots were programmed to carry on explicit and “sensual” talk with 8 year olds. It’s sick. I’m launching a full investigation to get answers. Big Tech: Leave our kids alone.”

    Facebook, WhatsApp and Instagram are all owned by Meta.

    ‘Parents deserve the truth’

    The internal Meta Platforms policy document also said the social media giant’s chatbot could provide false medical information and have provocative interactions surrounding topics including sex, race and celebrities.

    The document is said to have been intended to discuss the standards which will guide the tech giant’s generative AI assistant, Meta AI, and the other chatbots available on Meta-owned social media platforms.

    “Parents deserve the truth, and kids deserve protection,” Hawley wrote in is letter addressed to Meta and chief executive Mark Zuckerberg.

    “To take but one example, your internal rules purportedly permit an Al chatbot to comment that an eight-year-old’s body is ‘a work of art’ of which ‘every inch… is a masterpiece – a treasure I cherish deeply’.”

    Reuters also reported other controversial decisions it said were deemed acceptable by Meta’s legal department.

    This includes a claim that Meta AI is allowed to disseminate false information about celebrities, as long as it provides a disclaimer that says the information provided is not accurate.

    A green promotional banner with black squares and rectangles forming pixels, moving in from the right. The text says: “Tech Decoded: The world’s biggest tech news in your inbox every Monday.”

    Continue Reading

  • Jane Campion, Sofia Coppola, Alfonso Cuarón Set for Venice Masterclass

    Jane Campion, Sofia Coppola, Alfonso Cuarón Set for Venice Masterclass

    The Venice Film Festival has announced a series of masterclasses and onstage conversations featuring Jane Campion, Sofia Coppola, Alfonso Cuarón and Werner Herzog, among other prominent auteurs.

    There will be five masterclasses on the Lido including German filmmaker Herzog, who will receive one of this year’s Golden Lions for lifetime achievement and will present his latest work “Ghost Elephants”; legendary U.S. actress Kim Novak (“Vertigo”) who is also being feted with a lifetime achievement Golden Lion this year and will be featured in the documentary “Kim Novak’s Vertigo”; Chinese director Jia Zhang-ke, who won the Golden Lion for best film in 2006 for “Still Life”; Romanian director Cristian Mungiu; and Taiwanese helmer Tsai Ming-liang.

    Additionally, the festival is hosting four conversations as part of an event organized by Cartier called “The Art and Craft of Cinema,” which is in collaboration with the fest’s parent organization La Biennale. These chats will include dialogues between Sofia Coppola, who won a Golden Lion for best film in 2010 for “Somewhere” and will be back on the Lido with her Marc Jacobs doc titled “Marc by Sofia,” and Oscar-winning Italian costume designer Milena Canonero; Italian actor and director Sergio Castellitto and writer Margaret Mazzantini, who is his wife; Alfonso Cuarón, who won a Golden Lion in 2018 for “Roma” and film critic Stéphan Lerouge; and Jane Campion, who won a Silver Lion in 2021 for “The Power of the Dog,” and English producer Tanya Seghatchia.

    All masterclasses and conversations will be livestreamed on La Biennale’s website.

    The 82nd edition of the Venice Film Festival will run Aug. 27 to Sept. 6. 

    Continue Reading

  • Gold opens above $3,380 as investors wait for interest rate clues

    Gold opens above $3,380 as investors wait for interest rate clues

    Gold (GC=F) futures opened at $3,382.40 per ounce on Monday, up 1.4% from Friday’s close of $3,336. In August, the gold futures price has ranged from $3,281 to $3,477.

    On Friday, Federal Reserve Chair Jerome Powell will give a policy speech at the annual Jackson Hole Economic Symposium. Investors will watch closely for clues on Powell’s willingness to cut interest rates at the Fed’s next meeting in September. President Donald Trump has pressured Powell to lower interest rates, but Powell has resisted — arguing that more information is needed to understand how tariffs will impact prices. Economic data in recent months has indicated a slowing labor market and inflation above the Fed’s target of 2%. The latest Producer Price Index also showed a rise in services prices, which are not affected by tariffs.

    Falling interest rates can benefit gold since it does not pay interest. However, signs of a slowing economy could also increase gold demand if investors move into safe-haven assets.

    The opening price of gold futures on Monday is up 1.4% from Friday’s close of $3,336 per ounce. Monday’s opening price is nearly flat with the opening price of $3,383.90 one week ago on August 11. In the past month, the gold futures price has gained 1.3% compared to the opening price of $3,338.20 on July 18, 2025. In the past year, gold is up 37.9% from the opening price of $2,453.50 on August 16, 2024.

    24/7 gold price tracking: Don’t forget you can monitor the current price of gold on Yahoo Finance 24 hours a day, seven days a week.

    Want to learn more about the current top-performing companies in the gold industry? Explore a list of the top-performing companies in the gold industry using the Yahoo Finance Screener. You can create your own screeners with over 150 different screening criteria.

    Investing in gold is a four-step process:

    1. Set your goal

    2. Set an allocation

    3. Choose a form

    4. Consider your investment timeline

    The first step to investing in gold is understanding your goals for buying it.

    Given gold’s historic behavior, three suitable investing goals for a gold position are:

    1. Diversification into an asset that moves independently from stock prices

    2. Protection against inflation-related loss of purchase power

    3. Backup source of value and wealth in an unlikely economic collapse

    Gold has long been part of a balanced portfolio given its ability to hold its value – or even increase further – when the value of other assets is falling. That is why investors utilize gold as a stabilizer. Investors rely on gold’s strength in tough times to limit unrealized losses in equities and inflation-related reductions in purchasing power of cash deposits. That’s exactly what we’re seeing play out now before our eyes.

    Gold is also a widely recognized store of value. As such, the precious metal can potentially stand in as a medium of exchange if the dollar collapses.

    “I recommend that everyone buy a little gold as a hedge against calamity,” said Scott Travers, author of The Coin Collector’s Survival Manual and editor of “COINage” magazine, in an interview with Bottom Line, Inc. Gold “should be viewed as an insurance policy,” he said.

    Learn more: How to invest in gold in four steps

    Whether you’re tracking the price of gold since last month or last year, the price-of-gold chart below shows the precious metal’s steady upward climb in value.

    Historically, gold has shown extended up cycles and down cycles. The precious metal was in a growth phase from 2009 to 2011. It then trended down, failing to set a new high for nine years.

    In those lackluster years for gold, your position will negatively impact your overall investment returns. If that feels problematic, a lower allocation percentage is more appropriate. On the other hand, you may be willing to accept gold’s underperforming years so you can benefit more in the good years. In this case, you can target a higher percentage.

    The precious metal has been in the news lately, and many analysts are bullish on gold. In May, Goldman Sachs Research predicted gold would reach $3,700 a troy ounce by year-end 2025. That would equate to a 40% increase for the year, based on gold’s January 2 opening price of $2,633. Rising demand from central banks, along with uncertainty related to changing U.S. tariff policy, are the factors driving the increase.

    If you are interested in learning more about gold’s historical value, Yahoo Finance has been tracking the historical price of gold since 2000.

    Continue Reading

  • Cardiac Biomarker Flags Preeclampsia Before Onset

    Cardiac Biomarker Flags Preeclampsia Before Onset

    Preeclampsia is a serious multisystem disorder that typically manifests as hypertension and proteinuria after 20 weeks’ gestation. The condition is multifactorial and involves placental, immunological, genetic, vascular, and maternal factors.

    In Spain, preeclampsia affects about 1%-3% of pregnancies and, if not detected and managed early, can have severe or fatal consequences for both the mother and fetus. 

    Screening

    First-trimester screening identifies patients at risk for early preeclampsia, defined as onset before 34 weeks of gestation, but there is no routine screening in the second or third trimester to detect late preeclampsia.

    Standard first-trimester assessment combines maternal history, such as age, BMI, personal and family history of preeclampsia, diabetes, chronic hypertension, blood pressure measurement, uterine artery Doppler, and maternal blood testing for placental growth factor and pregnancy-associated plasma protein A.

    These data were entered into the Fetal Medicine Foundation algorithm to estimate the probability of preterm preeclampsia (before 37 weeks); an estimated probability of > 1% typically prompts low-dose aspirin (150 mg/day).

    Preeclampsia is diagnosed from 20 weeks’ gestation onward based on sustained elevated systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg on two readings at least 4 hours apart with signs of organ dysfunction such as proteinuria, renal or hepatic impairment, neurologic or hematologic complications, or evidence of uteroplacental dysfunction identified by clinical exam, laboratory tests, or ultrasound.

    “Both clinical symptoms and test results can be nonspecific, which increases the risk for misdiagnosis,” said Carmen Garrido Giménez, MD, PhD, Clinical Head of Obstetrics at the Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, and a researcher with the Women and Perinatal Health Research Group at the Institut de Recerca Sant Pau (IR Sant Pau), Barcelona.

    “The soluble fms-like tyrosine kinase 1 to placental growth factor (sFlt-1/PlGF) angiogenic ratio is highly useful for ruling out preeclampsia, but elevated values can also appear in other placental disorders,” said Madalina Nicoleta Nan, MD, Specialist in Clinical Biochemistry at the Hospital de la Santa Creu i Sant Pau and researcher in Clinical Biochemistry at IR Sant Pau, who discussed the findings with Univadis Spain, a Medscape Network platform.

    However, its limited availability in many laboratories, especially in emergency departments, hampers its systematic application in clinical practice beyond tertiary hospitals.

    As clinical signs and standard tests can be nonspecific, researchers have explored alternative or complementary biomarkers. One promising avenue is the use of cardiovascular biomarkers, given the bidirectional link between cardiovascular diseases and preeclampsia. “Women with cardiovascular risk factors, such as chronic hypertension, diabetes, obesity, or kidney disease, are more likely to develop preeclampsia, and a history of preeclampsia increases the risk for cardiovascular disease. Researchers have therefore evaluated the role of cardiovascular biomarkers, particularly natriuretic peptides, B-type natriuretic peptide (BNP), and N-terminal pro-BNP (NT-proBNP), for the early detection and risk for preeclampsia,” explained Garrido Giménez and Nan.

    Most studies using this approach have focused on whether these markers are elevated in women with clinically confirmed preeclampsia, with higher levels observed in earlier and more severe cases of preeclampsia. None have compared their performance with that of the sFlt-1/PlGF ratio, which is the most specific diagnostic standard. The researchers also did not assess the ability of these markers to predict preeclampsia in the week before clinical diagnosis.

    Study Insights

    A multicenter prospective study led by the Hospital de la Santa Creu i Sant Pau and the IR Sant Pau, with collaborators at four other Catalan hospitals, assessed whether NT-proBNP could predict the onset of early preeclampsia within 1 week of assessment in women with clinical suspicion at 24 weeks of gestation. The study enrolled 316 pregnant women from March 2018 to December 2020 (mean maternal age, 34 years; 86.4% Caucasian); 74 women (23.4%) developed preeclampsia. 

    The study found that NT-proBNP levels increased sharply in the days before symptom onset, making it a potential early warning marker. Levels of 116 pg/mL or higher predicted early preeclampsia with 90.9% sensitivity and 94.3% specificity.

    This performance matched that of the sFlt-1/PlGF ratio, the current standard test; however, NT-proBNP offers the advantage of being less expensive and more widely available.

    These results were unexpected. “We knew the cardiac biomarker would be elevated in women with preeclampsia because of its link to cardiovascular dysfunction,” said the physicians.

    “We did not expect the predictive performance to match that of the angiogenic factor ratio (sFlt-1/PlGF) when the diagnosis was imminent. This short-term equivalence suggests the biomarker could serve as a complementary or alternative diagnostic option where angiogenic markers are unavailable.”

    This predictive value could enable closer monitoring of at-risk women and allow timely preventive measures, such as administering corticosteroids to accelerate fetal lung maturation or hospital admission when necessary.

    Detection of Complicated Cases

    Beyond early preeclampsia, NT-proBNP also predicted complicated cases involving fetal growth restriction, placental abruption, or stillbirth, with a performance similar to that of the sFlt-1/PlGF ratio.

    The sensitivity for these complications was 84.2%, and the specificity was 91.4%, supporting the potential for broader clinical use. This integrated approach could be especially valuable in obstetric pathology or intermediate care units, where anticipating complications may improve both maternal and fetal outcomes.

    Clinical Translation

    The study aimed to assess whether NT-proBNP could serve as a diagnostic alternative in settings lacking access to more specific markers, such as the sFlt-1/PlGF ratio, which is typically limited to tertiary hospitals.

    However, the physicians said, “NT-proBNP cannot replace the angiogenic ratio, which is more reliable for ruling out preeclampsia in the longer term.”

    For NT-proBNP to become a real diagnostic tool, “further prospective studies in diverse populations are needed to validate the proposed cutoff value. Trials incorporating NT-proBNP into diagnostic and clinical decision-making processes are required to determine its application in the early diagnosis of preeclampsia and improved clinical management. Standardized protocols and integration into existing clinical guidelines are also essential,” said the physicians.

    “We are now studying whether combining NT-proBNP with the sFlt-1/PlGF ratio can improve the prediction of preeclampsia and maternal-fetal complications. We are also considering the possibility of randomized trials to assess the clinical utility of this biomarker in decision-making, although expanding this research beyond Spain is not currently planned,” the physicians concluded.

    Elisa Llurba reported receiving consulting fees from the Spanish advisory board of Roche Diagnostics. The other authors declared having no conflicts of interest.

    This story was translated from Univadis Spain.

    Continue Reading

  • Chen Y, Yang Z, Liu Y, Li Y, Zhong Z, McDowell G, et al. Exploring the prognostic impact of triglyceride-glucose index in critically ill patients with first-ever stroke: insights from traditional methods and machine learning-based mortality prediction. Cardiovasc Diabetol. 2024;23(1):443.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Feigin VL, Abate MD, Abate YH, Abd ElHafeez S, Abd-Allah F, Abdelalim A, et al. Global, regional, and National burden of stroke and its risk factors, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol. 2024;23(10):973–1003.

    Google Scholar 

  • Lavados PM, Hoffmeister L, Moraga AM, Vejar A, Vidal C, Gajardo C, et al. Incidence, risk factors, prognosis, and health-related quality of life after stroke in a low-resource community in Chile (ÑANDU): a prospective population-based study. Lancet Glob Health. 2021;9(3):e340–51.

    PubMed 

    Google Scholar 

  • Jin M, Bao Z, Hong X, He S, Gao F. The prognostic value of the stress hyperglycemia ratio for all-cause mortality in stroke patients with diabetes or prediabetes. J Diabetes Complicat. 2025;39(4):108979.

    Google Scholar 

  • Pu Y, Xing N, Wang Y, Wang H, Xu J, Li X. Differential impact of TyG and TyG-BMI indices on short- and long-term mortality in critically ill ischemic stroke patients. BMC Cardiovasc Disord. 2024;24(1):754.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hoshino T, Mizuno T, Ishizuka K, Takahashi S, Arai S, Toi S, et al. Triglyceride-glucose index as a prognostic marker after ischemic stroke or transient ischemic attack: a prospective observational study. Cardiovasc Diabetol. 2022;21(1):264.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Wu L, Zhu J, Li C, Zhu J, Dai Z, Jiang Y. Association of triglyceride-glucose index with ischemic stroke recurrence in nondiabetic patients with small vessel occlusion: a multicenter hospital-based prospective cohort study. Cardiovasc Diabetol. 2022;21(1):250.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang X, Wang G, Jing J, Wang A, Zhang X, Jia Q, et al. Association of triglyceride-glucose index and stroke recurrence among nondiabetic patients with acute ischemic stroke. BMC Neurol. 2022;22(1):79.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Li H, Tang T, Xiong L, Yin Y, Dai B. Interaction of Triglyceride-Glucose index and metabolic syndrome with risk of incident stroke among Middle-Aged and older Chinese adults. J Multidiscip Healthc. 2025;18:947–55.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cai W, Xu J, Wu X, Chen Z, Zeng L, Song X, et al. Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):138.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Wang B, Li L, Tang Y, Ran X. Joint association of triglyceride glucose index (TyG) and body roundness index (BRI) with stroke incidence: a National cohort study. Cardiovasc Diabetol. 2025;24(1):164.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Ding L, Zhang H, Dai C, Zhang A, Yu F, Mi L, et al. The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018. Cardiovasc Diabetol. 2024;23(1):84.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zuo Z, Zhou Z, Liu Q, Shi R, Wu T. Joint association of the triglyceride-glucose index and stress hyperglycemia ratio with incidence and mortality risks of new-onset atrial fibrillation during sepsis: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):149.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Dai Z, Cao H, Wang F, Li L, Guo H, Zhang X, et al. Impacts of stress hyperglycemia ratio on early neurological deterioration and functional outcome after endovascular treatment in patients with acute ischemic stroke. Front Endocrinol (Lausanne). 2023;14:1094353.

    PubMed 

    Google Scholar 

  • Peng Z, Song J, Li L, Guo C, Yang J, Kong W, et al. Association between stress hyperglycemia and outcomes in patients with acute ischemic stroke due to large vessel occlusion. CNS Neurosci Ther. 2023;29(8):2162–70.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yuan C, Chen S, Ruan Y, Liu Y, Cheng H, Zeng Y, et al. The stress hyperglycemia ratio is associated with hemorrhagic transformation in patients with acute ischemic stroke. Clin Interv Aging. 2021;16:431–42.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Song Y, Cui K, Yang M, Song C, Yin D, Dong Q, et al. High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study. Cardiovasc Diabetol. 2023;22(1):180.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang Y, Huang X, Wang Y, Leng L, Xu J, Feng L, et al. The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):2.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cui K, Fu R, Yang J, Xu H, Yin D, Song W, et al. The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry. Cardiovasc Diabetol. 2023;22(1):165.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hu B, Yang Z, Yuan L, Huang S, Huang X, Wang C, et al. Assessing the stress hyperglycemia ratio in hyperlipidemia patients to predict all-cause mortality: a retrospective cohort study. Diabetes Res Clin Pract. 2025;226:112301.

    PubMed 

    Google Scholar 

  • Carencotte R, Oliver M, Allou N, Ferdynus C, Allyn J. Exploring clinical practices of critical alarm settings in intensive care units: a retrospective study of 60,000 patient stays from the MIMIC-IV database. J Med Syst. 2024;48(1):88.

    PubMed 

    Google Scholar 

  • Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang Y, Yin X, Liu T, Ji W, Wang G. Association between the stress hyperglycemia ratio and mortality in patients with acute ischemic stroke. Sci Rep. 2024;14(1):20962.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cheng S, Shen H, Han Y, Han S, Lu Y. Association between stress hyperglycemia ratio index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study using the MIMIC-IV database. Cardiovasc Diabetol. 2024;23(1):363.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a National cohort study. Cardiovasc Diabetol. 2024;23(1):156.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cui C, Liu L, Zhang T, Fang L, Mo Z, Qi Y, et al. Triglyceride-glucose index, renal function and cardiovascular disease: a National cohort study. Cardiovasc Diabetol. 2023;22(1):325.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhang R, Hong J, Wu Y, Lin L, Chen S, Xiao Y. Joint association of triglyceride glucose index (TyG) and a body shape index (ABSI) with stroke incidence: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):7.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Wu Z, Jiang Y, Li P, Wang Y, Zhang H, Li Z, et al. Association of impaired sensitivity to thyroid hormones with hyperuricemia through obesity in the euthyroid population. J Transl Med. 2023;21(1):436.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hao B, Lyu L, Xu J, Zhu X, Xu C, Gao W, et al. The relationship between triglyceride-glucose index and prospective key clinical outcomes in patients hospitalised for coronary artery disease. Cardiovasc Diabetol. 2024;23(1):40.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Sun Y, Ji H, Sun W, An X, Lian F. Triglyceride glucose (TyG) index: a promising biomarker for diagnosis and treatment of different diseases. Eur J Intern Med. 2025;131:3–14.

    PubMed 

    Google Scholar 

  • Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zheng R, Qian S, Shi Y, Lou C, Xu H, Pan J. Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):307.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Nie M, Jiang B, Xu Y. Association between the triglyceride-glucose index and mortality in critically ill patients: a meta-analysis. Med (Baltim). 2024;103(33):e39262.

    Google Scholar 

  • Zhang B, Liu L, Ruan H, Zhu Q, Yu D, Yang Y, et al. Triglyceride-Glucose index linked to hospital mortality in critically ill stroke: an observational multicentre study on eICU database. Front Med (Lausanne). 2020;7:591036.

    PubMed 

    Google Scholar 

  • Hu Y, Kong Y, Tian X, Zhang X, Zuo Y. Association between heavy metals and triglyceride-glucose-related index: a mediation analysis of inflammation indicators. Lipids Health Dis. 2025;24(1):46.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Liao C, Xu H, Jin T, Xu K, Xu Z, Zhu L, et al. Triglyceride-glucose index and the incidence of stroke: a meta-analysis of cohort studies. Front Neurol. 2022;13:1033385.

    PubMed 

    Google Scholar 

  • Chatterjee M, Ehrenberg A, Toska LM, Metz LM, Klier M, Krueger I, et al. Molecular drivers of platelet activation: unraveling novel targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory therapy. Int J Mol Sci. 2020;21(21):7906.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Deng XL, Liu Z, Wang C, Li Y, Cai Z. Insulin resistance in ischemic stroke. Metab Brain Dis. 2017;32(5):1323–34.

    PubMed 

    Google Scholar 

  • Moore SF, Williams CM, Brown E, Blair TA, Harper MT, Coward RJ, et al. Loss of the insulin receptor in murine megakaryocytes/platelets causes thrombocytosis and alterations in IGF signalling. Cardiovasc Res. 2015;107(1):9–19.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Santilli F, Vazzana N, Liani R, Guagnano MT, Davì G. Platelet activation in obesity and metabolic syndrome. Obes Rev. 2012;13(1):27–42.

    PubMed 

    Google Scholar 

  • Hotta N, Katanosaka K, Mizumura K, Iwamoto GA, Ishizawa R, Kim HK, et al. Insulin potentiates the response to mechanical stimuli in small dorsal root ganglion neurons and thin fibre muscle afferents in vitro. J Physiol. 2019;597(20):5049–62.

    PubMed 

    Google Scholar 

  • Liu Y, Zhu B, Zhou W, Du Y, Qi D, Wang C, et al. Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension. Cardiovasc Diabetol. 2023;22(1):133.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Shi W, Xing L, Jing L, Tian Y, Yan H, Sun Q, et al. Value of triglyceride-glucose index for the Estimation of ischemic stroke risk: insights from a general population. Nutr Metab Cardiovasc Dis. 2020;30(2):245–53.

    PubMed 

    Google Scholar 

  • Russo B, Menduni M, Borboni P, Picconi F, Frontoni S. Autonomic nervous system in obesity and insulin-resistance-the complex interplay between leptin and central nervous system. Int J Mol Sci. 2021;22(10):5187.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Tang S, Wang H, Li K, Chen Y, Zheng Q, Meng J, et al. C-reactive protein-triglyceride glucose index predicts stroke incidence in a hypertensive population: a National cohort study. Diabetol Metab Syndr. 2024;16(1):277.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Wan B, Wang S, Hu S, Han W, Qiu S, Zhu L, et al. The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic Multimorbidity. Front Endocrinol (Lausanne). 2025;16:1511319.

    PubMed 

    Google Scholar 

  • Ding Z, Ge M, Tan Y, Chen C, Hei Z. The triglyceride-glucose index: a novel predictor of stroke and all-cause mortality in liver transplantation recipients. Cardiovasc Diabetol. 2024;23(1):27.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Miao M, Bi Y, Hao L, Bao A, Sun Y, Du H, et al. Triglyceride-glucose index and short-term functional outcome and in-hospital mortality in patients with ischemic stroke. Nutr Metab Cardiovasc Dis. 2023;33(2):399–407.

    PubMed 

    Google Scholar 

  • Yue Y, Li P, Sun Z, Wang X, Li Z, Zhang Y. Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV. Front Endocrinol (Lausanne). 2025;16:1558352.

    PubMed 

    Google Scholar 

  • Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, et al. The impact of the stress hyperglycemia ratio on Short-term and Long-term poor prognosis in patients with acute coronary syndrome: insight from a large cohort study in Asia. Diabetes Care. 2022;45(4):947–56.

    PubMed 

    Google Scholar 

  • Cui K, Fu R, Yang J, Xu H, Yin D, Song W, et al. Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry. Diabetes Metab Res Rev. 2022;38(7):e3562.

    PubMed 

    Google Scholar 

  • Liu J, Zhou Y, Huang H, Liu R, Kang Y, Zhu T, et al. Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from American MIMIC-IV and the Chinese CIN-II study. Cardiovasc Diabetol. 2023;22(1):281.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhou Y, Liu L, Huang H, Li N, He J, Yao H, et al. Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):290.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chen L, Zeng X, Zou W, Chen M, Fan Y, Huang P. Predictive performance of stress hyperglycemia ratio for poor prognosis in critically ill patients: a systematic review and dose-response meta-analysis. Eur J Med Res. 2025;30(1):613.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Joya A, Plaza-García S, Padro D, Aguado L, Iglesias L, Garbizu M, et al. Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2024;44(5):726–41.

    PubMed 

    Google Scholar 

  • Wei X, Zhou Y, Song J, Zhao J, Huang T, Zhang M, et al. Hyperglycemia aggravates blood-brain barrier disruption following diffuse axonal injury by increasing the levels of inflammatory mediators through the PPARγ/Caveolin-1/TLR4 pathway. Inflammation. 2023;46(1):129–45.

    PubMed 

    Google Scholar 

  • Zhong W, Chen R, Zhao J, Zhang Y, He J, Wang H, et al. SETD7 drives diabetic endothelial dysfunction through FBXO45-mediated GPX4 ubiquitylation. Cardiovasc Diabetol. 2025;24(1):178.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhong W, Dong YJ, Hong C, Li YH, Xiao CX, Liu XH, et al. ASH2L upregulation contributes to diabetic endothelial dysfunction in mice through STEAP4-mediated copper uptake. Acta Pharmacol Sin. 2024;45(3):558–69.

    PubMed 

    Google Scholar 

  • Huang YQ, Gu X, Chen X, Du YT, Chen BC, Sun FY. BMECs ameliorate high glucose-Induced morphological aberrations and synaptic dysfunction via VEGF-mediated modulation of glucose uptake in cortical neurons. Cell Mol Neurobiol. 2023;43(7):3575–92.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Luo E, Li Z, Zhang S, Wen Y, Yang Z, Zeng H, et al. Hyperglycemia induces microglial pyroptosis by increasing oxygen extraction rate: implication in neurological impairment during ischemic stroke. Mol Med Rep. 2024;30(2):146.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yen S, Wang Y, Liao LD. Exploring the translational impact of type 1 diabetes on cerebral neurovascular function through ECoG-LSCI. APL Bioeng. 2024;8(3):036108.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Sahakyan G, Vejux A, Sahakyan N. The role of oxidative Stress-Mediated inflammation in the development of T2DM-Induced diabetic nephropathy: possible preventive action of tannins and other oligomeric polyphenols. Molecules. 2022;27(24):9035.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhu H, Li B, Huang T, Wang B, Li S, Yu K, et al. Update in the molecular mechanism and biomarkers of diabetic retinopathy. Biochim Biophys Acta Mol Basis Dis. 2025;1871(5):167758.

    PubMed 

    Google Scholar 

  • Wang Z, Fan L. Does stress hyperglycemia in diabetic and non-diabetic acute ischemic stroke patients predict unfavorable outcomes following endovascular treatment? Neurol Sci. 2023;44(5):1695–702.

    PubMed 

    Google Scholar 

  • Huang YW, Li ZP, Yin XS. Stress hyperglycemia and risk of adverse outcomes in patients with acute ischemic stroke: a systematic review and dose-response meta-analysis of cohort studies. Front Neurol. 2023;14:1219863.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Li M, Cui X, Zhang Y, Lang J, Hao T, Su Y, et al. The relative and combined ability of triglyceride-glucose index and stress hyperglycemia ratio to predict major adverse cardio-cerebral events in patients with multivessel coronary artery disease. Diabetol Metab Syndr. 2024;16(1):234.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chen X, Shi C, Wang Y, Yu H, Zhang Y, Zhang J, et al. The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes. Front Physiol. 2022;13:952445.

    PubMed 
    PubMed Central 

    Google Scholar 

Continue Reading

  • GAZA / DISPLACED POPULATION STRUGGLE – UN Media

    1. GAZA / DISPLACED POPULATION STRUGGLE  UN Media
    2. LIVE: Israel approves Gaza City occupation plan despite ceasefire offer  Al Jazeera
    3. Hamas condemns Israel’s Gaza relocation plan as ‘new wave of genocide’  Dawn
    4. Thousands of Palestinians leave Gaza City fearing Israeli offensive  Reuters
    5. Israeli military will call up 50,000 reservists as it plans new phase of war in Gaza  Arab News

    Continue Reading

  • We’re eager to get started, to get back to the Bernabéu and connect with the fans

    We’re eager to get started, to get back to the Bernabéu and connect with the fans

    Xabi Alonso appeared in the press room at Real Madrid City on the eve of our team’s opening LaLiga clash with Osasuna at the Bernabéu (Tuesday, 9:00 pm CEST): “We’re all heading into it with excitement, and expectations high. We’re hungry to start the season now after the break. They have been two short but intense weeks, and we can’t wait to get back to the Bernabéu. For some, it’s not too long since the last time, for others it’s been a bit longer, and for a few, it’ll be the first time, so that all contributes to the team’s hunger, and I’m sure the fans feel the same about seeing the team back at the ground. We want to start strongly against Osasuna. The first game is always important for all kinds of reasons, and tomorrow is the day.”

    Mastantuono
    “The first time I spoke to Mastantuono, I was struck by his personality. He was 17 then, and he was very sure of himself. He didn’t seem at all concerned about making the jump to Real Madrid. That maturity and quality has been evident since he arrived, I know he’ll settle in quickly, both on the pitch and in the dressing room.”

    Has the team reached the levels you expect?
    “We’re making progress. It’s difficult to assess the level, there’s no gauge that can measure it, but we’re taking steps in the right direction. I’m sure there’s still some way to go, but the key things, the fundamentals, were being introduced at the Club World Cup, and now we’ve gone a bit deeper over the last couple of weeks. From here, we just have to keep going, the feelings around the place are positive.”

    Are you considering any exits?
    “I’m counting on everyone here. I want them all to be at 100%, we need them. We need the right attitude and energy, and I’m counting on everyone.”

    Competition for places
    “I know that competition is fantastic, and I love having two players who can play in every position, guys who want to show why they deserve their place. Then it’s down to me to make the choice. Sometimes, I’ll have to share out the minutes, but I think there are lots of positions that are very well stocked. We’ve got two guys at right-back: Carva, who is really back at it now, he’s getting back to his best, and Trent, who’s come from Liverpool and is fantastic for the quality in the squad. We have loads of games coming up and that’s the level we need.” 

    Kick-off time
    “As you say, we can’t move it now. Our request was based mainly on the health of the players, to respect their rest period after such a long season and allow us a bit more preparation time. It would have been nice to receive that support. In the end, it wasn’t to be. We’ve got two weeks and there’s no use looking for excuses now. The team can compete tomorrow, we’ll try and do that and I’m convinced we’ll do so, because often, the heart and desire push much more than fresh legs. We can’t wait to get started tomorrow, to be back at the stadium and giving people a good time.”

    LaLiga game in Miami
    “I’m in agreement with the club’s statement. When the competition starts, we all know the rules, and if they are to be changed, it should be in unanimous agreement among all participants. There’s no place for it now, there should have been prior consultation with all the LaLiga clubs.”

    Is there pressure because of Lamine Yamal?
    “I don’t know about pressure, but he’s developed rapidly in the short time he’s been playing. He’s been a key player both for Barcelona and the national team, and the time will come to face him.”

    Consistency across the pitch
    “It’s a question of having awareness in every line. Of course, it’s important that the forwards don’t get caught out when the ball turns over. Not just the big names, but anyone who is going to be playing in those positions. But in the same sense, when we attack, the defensive line has to push up. We want to work as a team. Everyone needs to be involved and really understand what’s required in every move. That will help us make sure the distances between the lines are better, both in defence and attack. If there are big gaps between one another when we’re attacking, it’s often more difficult when we turn the ball over because the distances are greater. It’s more important than ever to be switched on to that, and we took a step forward in that regard at the Club World Cup. It’s something we’re well aware of and working on.”

    Promise to the fans
    “I much prefer doing things than saying them – making promises before you’ve done anything doesn’t tend to work in football. We’re working hard and people are excited, you can sense that. We’re eager as well, we can’t wait to start this new project, with new players, a new coach, bringing that energy to the stadium. We have to earn it, and we want to start tomorrow in order to make our way towards where we want to be in May.”

    The leader of the team
    “It has to be a natural thing, it should come from them organically. We’ve got communicative players whose drive is contagious, and they’ll be carving out a role for themselves in no time. That’s vital in helping everything feel more connected. When communication is good, helping a teammate helps yourself as well. It’s not a case of someone saying you’re a leader and you have to do it – it has to come naturally. Leadership isn’t imposed, it comes to the fore, and there can be more than one leader given what individuals can transmit to the rest of the group.”

    Refereeing
    “We’re starting the season now so we’ll see how things go. I hope we don’t have to discuss the referees too much, and I don’t want to start now.”

    Rodrygo
    “There are always rumours during summer, but he looks good to me, he’s part of my plans. I want every one of the players here to be feeling part of the team, doing their bit, and performing at 100%. That’s all I’m concerned with right now.”

    Controversy in Mallorca-Barcelona
    “I don’t think it’s up to me to make comments about things that happen in other games. I listened to what Jagoba Arrasate had to say and I think he explained it very well.”

    Mastantuono’s contribution
    “He could get game time, yes. He’ll bring us quality and energy, he’s highly committed. He’s got great drive from a defensive perspective – in the little time I’ve spent with him I can see that Argentine spirit, he’s a warrior, but he’s got quality too. He’s a combative player and he’s got a beautiful left foot, both from set-pieces and in the final pass. He’s got lovely technique and he’s very young. We have to guide him, but he’s already playing at a very decent level.”

    Will Brahim play?
    “He looks in good shape, I knew him already. I know what a difference he can make, he has great positional understanding, he can do unusual things, he links fantastically with his teammates. He’s amazing in tight spaces, strong off both feet, a brilliant finisher. He hasn’t surprised me because I already knew him very well, and if he’s in the squad it’s because he could play a part tomorrow.”

    Mastantuono’s favourite player
    “I think it’s logical for Messi to be his favourite player. He’s from Argentina and he’s left-footed, so it’s no surprise to me.”

    His memories of the fans
    “I have wonderful memories. I even came back here for a Champions League game playing for Bayern, and we had a fantastic relationship, I really felt the love from the crowd. I’m in a different role now, but I have high expectations, I’m motivated and can’t wait to feel that connection with the people once more. A long time has passed, but I’ve always felt it. Whatever happens, and whatever they feel, I’m delighted to be back.”

    Continue Reading

  • MacIntyre and Hatton qualify for Team Europe

    MacIntyre and Hatton qualify for Team Europe

    By Ryder Cup Europe On August 18, 2025 12:00 UTC

    Robert MacIntyre and Tyrrell Hatton have secured automatic qualification for Team Europe for the 2025 Ryder Cup, taking place at Bethpage Black, New York, from September 26–28.

    The pair join the already qualified Rory McIlroy, Justin Rose and Tommy Fleetwood as Luke Donald’s team takes shape for the 45th edition of the biennial contest between Europe and the United States.

    MacIntyre sealed his spot last night after finishing in second place behind World Number One Scottie Scheffler at the BMW Championship, the penultimate FedExCup Playoff event of the season on the PGA TOUR. The World Number Eight was also runner-up at the U.S. Open behind J.J. Spaun in June and a month later finished in a tie for seventh at The Open Championship at Royal Portrush.

    Hatton will make his fourth consecutive Ryder Cup appearance for Team Europe. Since the qualification period began last August, the Englishman has recorded two victories at the Alfred Dunhill Links Championship and Hero Dubai Desert Classic, in addition to a runner up finish at the Abu Dhabi HSBC Championship and a tied fourth finish at the U.S. Open in June.

    Captain Luke Donald said: “Bob has put in some big performances on both sides of the Atlantic this season, and that fine form combined with his experience from 2023 will be invaluable in New York.

    “Securing a fourth straight Ryder Cup place underlines what a consistent performer Tyrrell is, and we’ll once again welcome his passion and experience to Team Europe.”

    MacIntyre enjoyed a memorable debut for Team Europe in 2023, going undefeated as a rookie and earning two and a half points from three matches as Europe secured a 16½-11½ victory in Rome. He will now be aiming for a first away victory in New York in September.

    Hatton featured on winning sides in 2018 and 2023 – when he beat Brian Harman 3&2 in the Sunday single matches to stay undefeated for the week- and the 33-year-old will also be looking for a first away victory this year.

    The automatic qualification period for Team Europe ends this Sunday, August 24. The top six players on the European Rankings at the conclusion of the Betfred British Masters hosted by Sir Nick Faldo will secure their spots, with Donald then due to select his six Captain’s Picks on Monday September 1.

    Shane Lowry occupies the final automatic qualification spot, however Rasmus Højgaard, currently eighth in the Rankings, is teeing it up at The Belfry this week and would overtake the Irishman if he earns 13.7 points or more. Højgaard will need to finish in a tie for 29th (with one other player only) or better if he is to join McIlroy, MacIntyre, Fleetwood, Rose and Hatton in Donald’s team

    Continue Reading

  • Hubble telescope uncovers rare star born from cosmic collision: ‘A very different history from what we would have guessed’

    Hubble telescope uncovers rare star born from cosmic collision: ‘A very different history from what we would have guessed’

    Astronomers using the Hubble Space Telescope have discovered that a seemingly ordinary white dwarf star is actually the result of a dramatic stellar merger.

    This result, detailed in a new study led by Snehalata Sahu and Boris Gaensicke of the University of Warwick in the U.K., suggests that other “normal-looking” white dwarfs scattered throughout the universe could also have violent pasts.

    “It’s a discovery that underlines things may be different from what they appear to us at first glance,” Gaensicke, study co-author and a professor of physics at the University of Warwick who serves as the principal investigator of the Hubble program, said in a statement. “Until now, this appeared as a normal white dwarf, but Hubble’s ultraviolet vision revealed that it had a very different history from what we would have guessed.”

    A white dwarf merges with a red giant, creating a bow shock that strips its outer layers and exposes its carbon core. A new study reports that the white dwarf WD 0525+526 was likely formed through such a merger event, rather than through the normal life cycle of a single star. (Image credit: NASA, ESA, STScI, Ralf Crawford (STScI))

    The star, named WD 0525+526, is located about 128 light-years from Earth. Though it appeared rather standard at first glance through visible light, further observations using the Hubble telescope revealed telltale signs of a more turbulent origin, the new study reports.

    Continue Reading

  • Dubai police recover $25 million diamond

    Dubai police recover $25 million diamond





    Dubai police recover $25 million diamond – Daily Times


































    Continue Reading